Table 1 summarizes the clinicopathological characteristics of the patients, stratified by EGFR status. EGFR mutation was associated with a no-to-moderate smoking history (pack-years < 40; p = 0.02) and a well-differentiated tumor (p < 0.0001). Here, EGFR is linked to neoplasm.